Integration with Venmo on The Knot’s Wedding Registry gives guests a familiar and trusted way to contribute to registry cash funds, while keeping registry tracking all in one place
NEW YORK--(BUSINESS WIRE)-- Today, The Knot Worldwide (TKWW), a leading global wedding technology platform and marketplace, announced Venmo, a money movement app for the next generation, is now a payment option within The Knot’s Wedding Registry. This provides a free and trusted way... (continue reading...)
PARIS & SINGAPORE--(BUSINESS WIRE)-- Amundi, the largest European asset manager, CACEIS, the European leader in asset servicing, and Ant International, a leading global digital payment, digitisation and financial technology company today announced milestones in their collaboration.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615998606/en/
From left to right: Jean-Jacques Barbéris, Deputy CEO of... (continue reading...)
Global cybersecurity company expands investment in India to strengthen business resilience, support compliance readiness, and deepen access to local talent
BURLINGTON, Mass.--(BUSINESS WIRE)-- N-able, Inc. (NYSE: NABL), a global cybersecurity company delivering business resilience, today announced the opening of its new Global Capability Centre (GCC) in Bengaluru, marking a strategic investment in India as the company expands its global security footprint in one of... (continue reading...)
Phase 2 operations delivering critical reservoir production and confirming lithium brine concentrations to advance final engineering design work
CALGARY, Alberta--(BUSINESS WIRE)-- E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), “E3”, “E3 Lithium” or the “Company,” a leader in Canadian lithium development, has successfully commissioned Phase 2 of its Clearwater Project Demonstration Facility (the “Demo Facility”) and continues to operate the reservoir... (continue reading...)
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner.
STOCKHOLM & LUND, Sweden--(BUSINESS WIRE)-- Pelago Bioscience, a specialist drug discovery focused contract research organization... (continue reading...)
More Business Wire
View Older Stories-
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
-
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era
-
Electro Optic Systems to Establish European C2 AI Hub in France
-
Novatus Global Appoints Andrew Pinnington as Chief Customer Officer
-
Forsee Power and Wabtec Collaborate to Equip Locomotives With Advanced Battery Systems
-
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
-
Azafaros to Present at BIO International Convention 2026
-
ACI Worldwide and EPI to Power Instant Payments in Europe
-
UFC® Names World Liberty Financial Official Partner of UFC® FREEDOM 250
-
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone
-
Sudarshan Chemical Inaugurates Second Global Head Office in Frankfurt
-
CnerG Acquires Monsoon Carbon to Expand Environmental Commodity Access Across Emerging Markets
-
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on the FF EAI Robotics Education Ecosystem Strategy, Product Line & New EAI Device Launch Happening
-
ComEd Reaches 99% Restoration Following Multi-Day Severe Storm Event
-
CEL-SCI Corporation Announces Pricing of Offering
-
GoodVision AI and ATTO Research Sign MOU to Develop Korea’s First Supply Chain-Focused AI Data Centers
-
Oshkosh Defense Highlights Proven, Adaptable Tactical Mobility Solutions for Europe at Eurosatory 2026
-
Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva
-
OrsoBio Presents Positive Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and MASLD at ENDO 2026
-
AV Introduces TOM 50 RE, a Backpackable UGV for Rapid Reconnaissance and Explosive Ordnance Disposal
-
Navy Federal and the National Flag Foundation Team Up on Light to Unite Initiative for America’s 250th Anniversary
-
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
-
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
-
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged P
-
ComEd Continues Power Restoration Following Two Powerful Storms
-
Republic Technologies Inc. Provides Bi-Weekly Update On Annual Filings
-
TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
-
BlackRock ESG Capital Allocation Term Trust (ECAT) Announces Certified Results of 2026 Annual Shareholder Meeting
-
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 2026
-
Generational Group Advises The Nutmeg Companies, Inc. in its Sale to a Private Investment Group
-
BlackRock Announces Product Updates
-
KBRA Assigns Preliminary Ratings to Aspire Mortgage Trust 2026-3 (SPIRE 2026-3)
-
TechCreate Group Ltd. Issues Statement Addressing NYSE Delisting Procedure
-
KBRA Assigns Preliminary Ratings to OBX 2026-AHC2 Trust
-
Nutrien Cautions Investors Regarding Ocehan LLC’s Below Market “Mini-Tender” Offer
-
AM Best Issues Correction to Issue Credit Rating on Teachers Insurance and Annuity Association of America’s Surplus Notes
-
Freedom Holding Corp. Announces That It Has Launched an Offering of Its Common Stock
-
Liberty All-Star® Equity Fund Announces New Portfolio Manager
-
Skillsoft Announces New Employee Inducement Grant Under NYSE Rule 303A.08
-
Aqua New Jersey President Natalie Chesko Recognized for Outstanding Achievements in Construction Industry
-
Lineage, Inc. Declares Dividend for Second-Quarter 2026
-
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock
-
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Ce
-
Irenic Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 18, 2026
-
Forbright Announces Closing of Initial Public Offering
-
Savara Announces New Employment Inducement Grant
-
NYSE American to Commence Delisting Proceedings Against JM Group Limited (JMG)
-
NYSE American to Commence Delisting Proceedings Against TechCreate Group Ltd. (TCGL)

